Trinity Biotech (TRIB) Capital Expenditures Growth (1y) (2010 - 2024)
Trinity Biotech (TRIB) Capital Expenditures Growth (1y) (2010 - 2024) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Capex Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 199.63 Bn | 194.02 Bn | 7.27 Bn | -1.00% |
| 2 | Stryker | 127.42 Bn | 123.95 Bn | 4.50 Bn | 10.38% |
| 3 | Medtronic | 118.97 Bn | 109.75 Bn | 6.41 Bn | 6.32% |
| 4 | Boston Scientific | 73.39 Bn | 72.85 Bn | 3.85 Bn | 24.20% |
| 5 | Edwards Lifesciences | 51.97 Bn | 47.72 Bn | 1.35 Bn | 35.70% |
| 6 | Dexcom | 34.32 Bn | 32.37 Bn | 830.00 Mn | -9.99% |
| 7 | GE HealthCare Technologies | 33.76 Bn | 31.65 Bn | 2.18 Bn | 16.28% |
| 8 | Koninklijke Philips | 26.35 Bn | 23.03 Bn | 4.55 Bn | -4.32% |
| 9 | Steris | 23.04 Bn | 22.56 Bn | 684.20 Mn | -6.52% |
| 10 | Trinity Biotech | 6.46 Mn | 1.32 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2024 | 37.20% |
| Dec 31, 2023 | 47.37% |
| Sep 30, 2023 | 60.12% |
| Dec 31, 2022 | 16.67% |
| Jun 30, 2022 | 63.24% |
| Dec 31, 2016 | -0.60% |
| Dec 31, 2015 | -22.84% |
| Dec 31, 2014 | 22.99% |
| Dec 31, 2013 | 21.78% |
| Dec 31, 2012 | -7.80% |
| Dec 31, 2011 | -17.35% |
| Dec 31, 2010 | -13.84% |
| Sep 30, 2010 | 5.31% |
| Jun 30, 2010 | 41.09% |
| Mar 31, 2010 | 7.08% |